Gradient Investments’s AllianzIM U.S. Equity Buffer10 Feb ETF FEBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$56.7M Buy
1,378,809
+16,116
+1% +$648K 0.78% 33
2026
Q1
$51M Buy
1,362,693
+9,899
+0.7% +$380K 0.79% 33
2025
Q4
$51.5M Buy
1,352,794
+24,002
+2% +$900K 0.82% 31
2025
Q3
$49.2M Buy
1,328,792
+5,114
+0.4% +$184K 0.82% 34
2025
Q2
$46.5M Buy
+1,323,678
New +$43.9M 0.85% 33

Other funds holding FEBT

Gradient Investments's FEBT Position: Q2 2026 in Review

Gradient Investments increased its AllianzIM U.S. Equity Buffer10 Feb ETF (FEBT) stake by 1.2% in Q2 2026, buying an estimated $648K and bringing the position to 1,378,809 shares worth $56.7M. The position accounts for 0.78% of the portfolio, ranked #33.

Gradient Investments first reported a position in FEBT in Q2 2025 and has held it in 5 quarters since. 30 funds tracked by Wall St. Rank hold FEBT as of Q2 2026.

  • Gradient Investments held 1,378,809 shares of AllianzIM U.S. Equity Buffer10 Feb ETF worth $56.7M as of Q2 2026.
  • Gradient Investments bought 16,116 AllianzIM U.S. Equity Buffer10 Feb ETF shares in Q2 2026, an estimated $648K.
  • AllianzIM U.S. Equity Buffer10 Feb ETF made up 0.78% of Gradient Investments's portfolio in Q2 2026, its #33 holding.
  • Gradient Investments first reported a position in AllianzIM U.S. Equity Buffer10 Feb ETF in Q2 2025 and has held it in 5 quarters since.
  • 30 funds tracked by Wall St. Rank held AllianzIM U.S. Equity Buffer10 Feb ETF as of Q2 2026.

Based on Gradient Investments's 13F filing for Q2 2026, filed 8 Jul 2026.